AEONNN How It Works Pillars Membership FAQ Journal AEONNNian Access Request Early Access

The Foundational Longevity Stack: Where to Start

A first stack should be short, evidence-weighted and built on measurement. What belongs in one, what does not, and why the order of operations matters more than the list.

9 min read

The Short Answer

A foundational longevity stack is short: it addresses the inputs where inadequate intake is common and correction is well supported, and it stops there. In practice that means vitamin D3 titrated to a measured 25-hydroxyvitamin D concentration, omega-3 EPA and DHA titrated toward an omega-3 index in the 8 to 12 percent range, magnesium in a well-absorbed form where dietary intake is low, and creatine monohydrate for its combination of low cost and unusually broad evidence. Everything else is a candidate for a second layer, and none of it substitutes for the four interventions that outperform any stack: training, sleep, energy balance and not smoking.

The Order of Operations

Before any compound, four things determine whether a stack has anything meaningful to add.

Training. Cardiorespiratory fitness and muscle mass are among the strongest predictors of mortality and functional independence in the human literature. No supplement approaches their effect size, and a stack assembled by someone who does not train is filling in the least significant variable.

Sleep. Duration and regularity. Insufficient sleep degrades metabolic, inflammatory, hormonal and cognitive function simultaneously, which means work on other systems is being done at a discount.

Energy balance and body composition. Visceral adiposity drives inflammatory signalling and insulin resistance, and reducing it improves multiple markers at once.

Not smoking, and alcohol moderation. The largest single modifiable factor and a dose-dependent second one.

This is not a rhetorical preamble. It is the reason a foundational stack should be small: most of the available effect has already been claimed by the items above, and a supplement's job is to correct specific inadequacies rather than to substitute for them.

What Belongs in a Foundational Stack

Vitamin D3, titrated to measurement

Habitual status is inadequate for a large share of the population above roughly 37 degrees latitude, particularly in winter, and individual response to a fixed dose varies severalfold. That combination makes it the clearest case for measurement-guided supplementation. Common maintenance intakes fall between 1,000 and 4,000 IU per day, taken with a fat-containing meal, with a target 25-hydroxyvitamin D concentration in the 30 to 40 ng/mL (75 to 100 nmol/L) range. Vitamin K2 as MK-7 at 90 to 200 mcg per day is a mechanistically coherent companion, though the evidence for the combination specifically is still limited.

Omega-3 EPA and DHA

Directly measurable through the omega-3 index, which reflects membrane composition over months rather than the last meal. Most people without high fish intake sit between 4 and 6 percent against a commonly cited target of 8 to 12 percent. Nutritional intakes of 500 mg to 1 g per day of combined EPA and DHA suit general adequacy, with 2 grams or more per day where triglyceride reduction or an inflammatory objective applies. Product oxidation is the quality issue that matters here more than the delivery form.

Magnesium, where intake is low

A cofactor for hundreds of enzymatic reactions, with habitual intakes below recommendations for a large fraction of adults eating a processed diet. Form should follow objective: glycinate for sleep, stress and general repletion; citrate where a mild laxative effect is acceptable; threonate for cognitive objectives. Serum magnesium is a poor status measure, so this is one of the few cases where dietary assessment and a supplementation trial are more informative than a blood test.

Creatine monohydrate

The most-studied performance supplement in existence, with an unusually broad evidence base extending beyond muscle into cognitive effects under sleep deprivation and in vegetarians with lower baseline stores. It is inexpensive, has a strong safety record across decades of use, and supports the phosphocreatine energy buffer in muscle and brain. Three to five grams per day, no loading phase required, timing largely irrelevant.

Protein adequacy

Not a supplement so much as a nutritional target, and the most consequential item in this section for anyone over forty. Muscle mass preservation depends on it, anabolic sensitivity declines with age, and a protein powder is a convenience rather than a compound.

The Second Layer, and When It Applies

These are reasonable additions once the foundation is in place and where a specific objective or finding justifies them.

  • B12, where intake is low or absorption is impaired. Relevant for vegetarians and vegans, for anyone over sixty, and for anyone on long-term proton pump inhibitors or metformin.
  • Fibre supplementation, where dietary intake is inadequate. Psyllium or partially hydrolysed guar gum. Cheap, and it does more for the microbiome than a probiotic in most cases.
  • Glycine, for sleep onset. Modest evidence, low cost, gentle.
  • Berberine, where glycaemic markers warrant it. The strongest glycaemic evidence in the supplement space, with a real interaction profile requiring a medication check.
  • CoQ10, in specific contexts. Migraine frequency, statin-associated muscle symptoms, and older adults where absorption favours ubiquinol.
  • A daily multivitamin. Unfashionable, and several recent randomised trials in older adults reported modest cognitive benefits, which is better evidence than many single compounds carry.
  • Iron, only where indices demonstrate need. Never speculatively, since excess iron carries its own considerations.

What Does Not Belong in a First Stack

Not because these compounds are useless, but because they are second-order and frequently displace the items that matter.

  • NAD+ precursors. Reliably raise blood NAD+, with unproven functional benefit in healthy adults and several null muscle trials. Interesting, expensive, not foundational.
  • Resveratrol. Poor bioavailability, small and inconsistent metabolic effects, a specific reason for caution around training, and a real interaction profile.
  • Senolytics. Experimental. Human trials in progress with no published clinical endpoint results.
  • Long compound lists in general. Twelve compounds each acting weakly on one node do not reproduce the effect of one intervention acting on many, and each addition increases interaction surface, cost and adherence burden.
  • Anything at a dose that does not match the trial evidence. A token amount of an ingredient added for label appeal is not the intervention that was studied.
  • High-dose antioxidants around training. Actively counterproductive for adaptation.

Building It in Sequence

A structure that avoids the common failure of adding everything at once and learning nothing.

  1. Weeks 0 to 2: measure. A standard panel including full blood count, metabolic panel, lipids with ApoB, HbA1c, fasting insulin, high-sensitivity C-reactive protein, ferritin with iron studies, 25-hydroxyvitamin D, B12 and thyroid markers. An omega-3 index if available. Waist to height ratio, grip strength and a submaximal fitness measure cost nothing.
  2. Weeks 2 to 4: address the foundation. Training structure, sleep timing, protein target. No compounds yet beyond correcting anything the panel showed as clearly inadequate.
  3. Weeks 4 to 6: add the core, one at a time. Introducing compounds individually with several days between allows attribution of any effect or intolerance.
  4. Week 12 to 16: re-measure. The same panel under the same conditions. Compare against baseline, not against a reference interval.
  5. Then decide. Keep what has a reason, remove what does not, and add a second-layer item only against a specific finding.

The Review Discipline

The most valuable habit in supplementation is not selection. It is removal.

Stacks grow by accretion. A compound is added for a reason, the reason lapses, and the compound remains. After two years most people are taking several things whose original justification they could not state, at a cumulative cost and interaction surface nobody has reviewed.

The discipline that prevents this is simple and rarely practised: for every item in the stack, write down the objective, the observation window, and what would count as evidence to stop. Review that list quarterly. Anything without an answer comes out.

Specific review triggers matter as much as the calendar. Any new prescription medication requires an interaction re-check across the whole stack. A change in season or location changes the vitamin D dose. A change in training load changes protein and creatine relevance and the antioxidant timing question. A new laboratory result may resolve an objective or introduce one. None of these announce themselves in how a person feels.

The AEONNN Perspective

This is the article closest to what Stack Builder actually does, and the difference is instructive. A published foundational stack is a population-level default; Stack Builder produces a member-level output, which means the same four core items may appear with different doses, different forms, or not at all depending on the profile.

The measurement-first sequence is deliberate. Vitamin D and omega-3 are the two foundational items with direct status measurements, which is why Synched Mode changes the recommendation from a range to a titration. Magnesium is the opposite case: serum testing is uninformative, so the reasoning runs from dietary intake and reported signals, and the platform says so rather than implying a precision it does not have.

The removal discipline is the part AEONNN is built to automate. Insight Protocol attaches an objective and an observation window to each recommendation at the point it is made, and AEONNN Shield, in development, is designed to notice when a stack has drifted out of alignment with a member's current context. Stacks decay quietly, and expecting a member to audit their own reasoning quarterly is expecting the wrong thing from the wrong party.

Database Matrix layers

  • Evidence Layer (PubMed, Cochrane, ClinicalTrials.gov)
  • Meta / Consensus Layer (JAMA, BMJ, specialty society positions)
  • Safety Layer (DrugBank, FAERS)
  • Quality / Formulation Layer (ConsumerLab, Labdoor)
  • Population Layer (UK Biobank, NHANES)

Frequently Asked

What should a beginner longevity stack contain?

Vitamin D3 titrated to a measured 25-hydroxyvitamin D concentration, omega-3 EPA and DHA titrated toward an omega-3 index of 8 to 12 percent, magnesium in a well-absorbed form where dietary intake is low, and creatine monohydrate at 3 to 5 grams per day. Protein adequacy sits alongside these as a nutritional target.

Should I take NMN or resveratrol as a beginner?

Neither belongs in a first stack. NAD+ precursors raise blood NAD+ with unproven functional benefit in healthy adults, and resveratrol has poor bioavailability, inconsistent effects and a specific reason for caution around training.

Do I need blood tests before starting supplements?

For vitamin D and omega-3, measurement changes the recommendation from a guess to a titration, and individual response to vitamin D varies severalfold. For iron, testing is essential before supplementing. For magnesium, serum testing is uninformative, so dietary assessment is more useful.

Is creatine only for athletes?

No. It has an unusually broad evidence base including cognitive effects under sleep deprivation and in vegetarians with lower baseline stores, plus muscle mass support that matters more with age. It is inexpensive with a strong long-term safety record.

How many supplements is too many?

The practical limit is where you can no longer state the objective, the observation window and the stopping condition for each item. Beyond that, cost, interaction surface and adherence burden rise without corresponding benefit.

Is a multivitamin worth taking?

It is more defensible than its reputation suggests. Several recent randomised trials in older adults reported modest cognitive benefits, which is better evidence than many single-compound products carry. It does not replace correcting a specific measured inadequacy.

How often should a stack be reviewed?

Quarterly as a default, plus specific triggers: any new prescription medication, a change in season or location, a change in training load, and any new laboratory result. Removal matters more than addition.

Evidence and review

Any dosage ranges cited here reflect the ranges used in published human trials, not personal recommendations. Evidence in this field moves, so this article is reviewed quarterly and carries its last-updated date above. Nothing here is intended as medical advice, and supplementation should be discussed with a qualified clinician, particularly alongside prescribed medication or an existing condition.

Continue Reading

Membership

Reading about longevity and Biological Age is not the same as knowing where you stand.

AEONNN organizes an article like this one against your own profile. Origin works through Discovered Mode, building your Pillar Matrix from the context you provide. Evolution adds Synched Mode, so supported wearable, Apple Health and laboratory data inform the same reasoning.

AEONNN turns knowledge like this into a protocol that is yours.

Private Early Access opens in August. Public launch follows in September.

By requesting access, you agree to receive AEONNN launch and membership communications. You may unsubscribe at any time. Privacy Policy · Consumer Health Data Privacy Notice

Back to the Journal →